Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?

por Passiglia, Francesco, Novello, Silvia
Publicado 2020

A strategy to overcome EGFR p.T790M cis p.L792F induced resistance to osimertinib

por Malapelle, Umberto, Passiglia, Francesco
Publicado 2022

Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer?

por Passiglia, Francesco, Novello, Silvia
Publicado 2023

COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery

por Bungaro, Maristella, Passiglia, Francesco, Scagliotti, Giorgio V.
Publicado 2022

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?

por Passiglia, Francesco, Reale, Maria Lucia, Cetoretta, Valeria, Novello, Silvia
Publicado 2021

Improving lung cancer outcomes through smoking cessation: the Women Against Lung Cancer in Europe (WALCE) experience

por Capelletto, Enrica, Passiglia, Francesco, Ferraresi, Federica, Vallone, Stefania, Novello, Silvia
Publicado 2020

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?—a literature review

por Leone, Gianmarco, Passiglia, Francesco, Bironzo, Paolo, Bertaglia, Valentina, Novello, Silvia
Publicado 2020

Exploring the immune-checkpoint inhibitors’ efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease

por Passiglia, Francesco, Cetoretta, Valeria, De Filippis, Marco, Napoli, Valerio, Novello, Silvia
Publicado 2021

Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found…

por Thungappa, Satheesh, Ferri, Jose, Caglevic, Christian, Passiglia, Francesco, Raez, Luis, Rolfo, Christian
Publicado 2017

Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review

por Passiglia, Francesco, Bironzo, Paolo, Bertaglia, Valentina, Listì, Angela, Garbo, Edoardo, Scagliotti, Giorgio Vittorio
Publicado 2022

Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes

por Mogavero, Andrea, Bironzo, Paolo, Righi, Luisella, Merlini, Alessandra, Benso, Federica, Novello, Silvia, Passiglia, Francesco
Publicado 2023

Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway

por La Paglia, Laura, Listì, Angela, Caruso, Stefano, Amodeo, Valeria, Passiglia, Francesco, Bazan, Viviana, Fanale, Daniele
Publicado 2017

Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours

por Dumoulin, Daphne W., Bironzo, Paolo, Passiglia, Francesco, Scagliotti, Giorgio V., Aerts, Joachim G.J.V.
Publicado 2023

Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies

por Cani, Massimiliano, Napoli, Valerio Maria, Garbo, Edoardo, Ferrari, Giorgia, Del Rio, Benedetta, Novello, Silvia, Passiglia, Francesco
Publicado 2023

Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib

por Corrales, Luis, Nogueira, Amanda, Passiglia, Francesco, Listi, Angela, Caglevic, Christian, Giallombardo, Marco, Raez, Luis, Santos, Edgardo, Rolfo, Christian
Publicado 2017

Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—a trial-level meta-analysis in PD-L1 selected subgroups

por Passiglia, Francesco, Galvano, Antonio, Gristina, Valerio, Barraco, Nadia, Castiglia, Marta, Perez, Alessandro, La Mantia, Maria, Russo, Antonio, Bazan, Viviana
Publicado 2021

Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature Review

por Garbo, Edoardo, Del Rio, Benedetta, Ferrari, Giorgia, Cani, Massimiliano, Napoli, Valerio Maria, Bertaglia, Valentina, Capelletto, Enrica, Rolfo, Christian, Novello, Silvia, Passiglia, Francesco
Publicado 2023

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

por Passiglia, Francesco, Bronte, Giuseppe, Bazan, Viviana, Natoli, Clara, Rizzo, Sergio, Galvano, Antonio, Listì, Angela, Cicero, Giuseppe, Rolfo, Christian, Santini, Daniele, Russo, Antonio
Publicado 2016

The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis

por Passiglia, Francesco, Rizzo, Sergio, Di Maio, Massimo, Galvano, Antonio, Badalamenti, Giuseppe, Listì, Angela, Gulotta, Leonardo, Castiglia, Marta, Fulfaro, Fabio, Bazan, Viviana, Russo, Antonio
Publicado 2018

Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis

por Passiglia, Francesco, Rizzo, Sergio, Di Maio, Massimo, Galvano, Antonio, Badalamenti, Giuseppe, Listì, Angela, Gulotta, Leonardo, Castiglia, Marta, Fulfaro, Fabio, Bazan, Viviana, Russo, Antonio
Publicado 2018